Selective killing of ATM- or p53-deficient cancer cells through inhibition of ATR
Year: 2011
Type: article
Source: Nature Chemical Biology
DOI: 10.1038/nchembio.573
Institution: Vertex Pharmaceuticals (United Kingdom)
Language: English
Topic: DNA Repair Mechanisms
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2022529631